{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:47:45Z","timestamp":1785930465621,"version":"3.56.0"},"publisher-location":"Berlin, Heidelberg","reference-count":79,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2025_337","type":"book-chapter","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:35:06Z","timestamp":1770132906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Biology and Clinical Utility of EBV Monitoring in Blood"],"prefix":"10.1007","author":[{"given":"Laura F.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena R.","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"6","key":"337_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMe1706815","volume":"377","author":"RF Ambinder","year":"2017","unstructured":"Ambinder RF (2017) Plasma Epstein-Barr virus DNA for screening. N Engl J Med 377(6):584\u2013585. https:\/\/doi.org\/10.1056\/NEJMe1706815","journal-title":"N Engl J Med"},{"issue":"1","key":"337_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243\u2013249. https:\/\/doi.org\/10.1182\/blood-2003-12-4197","journal-title":"Blood"},{"issue":"4","key":"337_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA (1999) Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190(4):567\u2013576. https:\/\/doi.org\/10.1084\/jem.190.4.567","journal-title":"J Exp Med"},{"key":"337_CR4","doi-asserted-by":"publisher","unstructured":"Balfour HH, Meirhaeghe MR (2025) Infectious mononucleosis. Curr Top Microbiol Immunol. https:\/\/doi.org\/10.1007\/82_2025_286","DOI":"10.1007\/82_2025_286"},{"key":"337_CR5","doi-asserted-by":"publisher","first-page":"199157","DOI":"10.1016\/j.virusres.2023.199157","volume":"334","author":"KDE Bernal","year":"2023","unstructured":"Bernal KDE, Whitehurst CB (2023) Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res 334:199157. https:\/\/doi.org\/10.1016\/j.virusres.2023.199157","journal-title":"Virus Res"},{"issue":"224","key":"337_CR6","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra24. https:\/\/doi.org\/10.1126\/scitranslmed.3007094","journal-title":"Sci Transl Med"},{"issue":"4","key":"337_CR7","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1086\/499956","volume":"42","author":"S Bossolasco","year":"2006","unstructured":"Bossolasco S, Falk KI, Ponzoni M, Ceserani N, Crippa F, Lazzarin A et al (2006) Ganciclovir Is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma. Clin Infect Dis 42(4):e21\u2013e25. https:\/\/doi.org\/10.1086\/499956","journal-title":"Clin Infect Dis"},{"issue":"22","key":"337_CR8","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1182\/blood-2010-05-285452","volume":"116","author":"S Calattini","year":"2010","unstructured":"Calattini S, Sereti I, Scheinberg P, Kimura H, Childs RW, Cohen JI (2010) Detection of EBV genomes in plasmablasts\/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH. Blood 116(22):4546\u20134559. https:\/\/doi.org\/10.1182\/blood-2010-05-285452","journal-title":"Blood"},{"issue":"1","key":"337_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/lary.24193","volume":"124","author":"JYW Chan","year":"2014","unstructured":"Chan JYW, Wong ST-S (2014) The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma. The Laryngoscope 124(1):126\u2013130. https:\/\/doi.org\/10.1002\/lary.24193","journal-title":"The Laryngoscope"},{"issue":"10","key":"337_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/cncr.28001","volume":"119","author":"KC Chan","year":"2013","unstructured":"Chan KC, Hung EC, Woo JK, Chan PK, Leung SF, Lai FP et al (2013) Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer 119(10):1838\u20131844. https:\/\/doi.org\/10.1002\/cncr.28001","journal-title":"Cancer"},{"issue":"6","key":"337_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KA Chan","year":"2017","unstructured":"Chan KA, Woo JK, King A, Zee BC, Lam WJ, Chan SL et al (2017) Analysis of plasma Epstein\u2013Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med 377(6):513\u2013522","journal-title":"N Engl J Med"},{"issue":"7","key":"337_CR12","doi-asserted-by":"publisher","first-page":"EVIDoa2200309","DOI":"10.1056\/EVIDoa2200309","volume":"2","author":"KCA Chan","year":"2023","unstructured":"Chan KCA, Lam WKJ, King A, Lin VS, Lee PPH, Zee BCY et al (2023) Plasma Epstein-Barr virus DNA and risk of future nasopharyngeal cancer. NEJM Evid 2(7):EVIDoa2200309. https:\/\/doi.org\/10.1056\/EVIDoa2200309","journal-title":"NEJM Evid"},{"issue":"10","key":"337_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269766","volume":"17","author":"YC Chang","year":"2022","unstructured":"Chang YC, Young RR, Mavis AM, Chambers ET, Kirmani S, Kelly MS et al (2022) Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients. PLoS One 17(10):e0269766. https:\/\/doi.org\/10.1371\/journal.pone.0269766","journal-title":"PLoS One"},{"issue":"8","key":"337_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00277-018-3313-x","volume":"97","author":"J Cho","year":"2018","unstructured":"Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y et al (2018) Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Ann Hematol 97(8):1427\u20131436. https:\/\/doi.org\/10.1007\/s00277-018-3313-x","journal-title":"Ann Hematol"},{"issue":"5","key":"337_CR15","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/jvi.70.5.3286-3289.1996","volume":"70","author":"LL Decker","year":"1996","unstructured":"Decker LL, Klaman LD, Thorley-Lawson DA (1996) Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 70(5):3286\u20133289","journal-title":"J Virol"},{"issue":"6","key":"337_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/jco.2012.45.2011","volume":"32","author":"LA Diaz","year":"2014","unstructured":"Diaz LA, Bardelli A (2014) Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32(6):579\u2013586. https:\/\/doi.org\/10.1200\/jco.2012.45.2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"337_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM (2018) Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378(6):549\u2013562. https:\/\/doi.org\/10.1056\/NEJMra1702693","journal-title":"N Engl J Med"},{"issue":"7","key":"337_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1086\/500839","volume":"193","author":"D Donati","year":"2006","unstructured":"Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, Lundkvist A et al (2006) Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 193(7):971\u2013977. https:\/\/doi.org\/10.1086\/500839","journal-title":"J Infect Dis"},{"issue":"3","key":"337_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ccell.2023.12.020","volume":"42","author":"X-J Du","year":"2024","unstructured":"Du X-J, Wang G-Y, Zhu X-D, Han Y-Q, Lei F, Shen L-F et al (2024) Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma. Cancer Cell 42(3):464\u2013473.e3. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.020","journal-title":"Cancer Cell"},{"issue":"6","key":"337_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/428097","volume":"191","author":"S Fafi-Kremer","year":"2005","unstructured":"Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R et al (2005) Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis 191(6):985\u2013989. https:\/\/doi.org\/10.1086\/428097","journal-title":"J Infect Dis"},{"issue":"1","key":"337_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jmv.20238","volume":"75","author":"H Fan","year":"2005","unstructured":"Fan H, Kim SC, Chima CO, Israel BF, Lawless KM, Eagan PA et al (2005) Epstein\u2013Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol 75(1):59\u201369. https:\/\/doi.org\/10.1002\/jmv.20238","journal-title":"J Med Virol"},{"issue":"2","key":"337_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijid.2006.04.001","volume":"11","author":"MD Fellner","year":"2007","unstructured":"Fellner MD, Durand K, Correa RM, Redini L, Yampolsky C, Colobraro A et al (2007) Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Int J Infect Dis 11(2):172\u2013178. https:\/\/doi.org\/10.1016\/j.ijid.2006.04.001","journal-title":"Int J Infect Dis"},{"issue":"1","key":"337_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cyto.a.24680","volume":"103","author":"JJ Freen-van Heeren","year":"2023","unstructured":"Freen-van Heeren JJ (2023) Investigating EBV biology with Flow-FISH: implications for EBV-mediated malignancies and the treatment thereof. Cytometry Part A 103(1):5\u20137. https:\/\/doi.org\/10.1002\/cyto.a.24680","journal-title":"Cytometry Part A"},{"issue":"2","key":"337_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1078-0432.Ccr-05-2008","volume":"12","author":"MK Gandhi","year":"2006","unstructured":"Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ et al (2006) Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin\u2019s lymphoma. Clin Cancer Res 12(2):460\u2013464. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"337_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cncr.31741","volume":"125","author":"R Guo","year":"2019","unstructured":"Guo R, Tang L-L, Mao Y-P, Du X-J, Chen L, Zhang Z-C et al (2019) Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 125(1):79\u201389. https:\/\/doi.org\/10.1002\/cncr.31741","journal-title":"Cancer"},{"key":"337_CR26","doi-asserted-by":"publisher","first-page":"594692","DOI":"10.3389\/fonc.2020.594692","volume":"10","author":"JY Ha","year":"2020","unstructured":"Ha JY, Cho H, Sung H, Jung AR, Lee YS, Lee SW et al (2020) Superiority of Epstein-Barr Virus DNA in the plasma over whole blood for prognostication of extranodal NK\/T cell lymphoma. Front Oncol 10:594692. https:\/\/doi.org\/10.3389\/fonc.2020.594692","journal-title":"Front Oncol"},{"key":"337_CR27","doi-asserted-by":"publisher","unstructured":"Heldman MR, Chang Y-C, Saullo J, Baker AW, Maziarz EK, Tam PC et al (2023) Limited utility of Epstein-Barr Virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorder in EBV seropositive adult lung transplant recipients. Open Forum Infect Dis 10(Supplement_2). https:\/\/doi.org\/10.1093\/ofid\/ofad500.705","DOI":"10.1093\/ofid\/ofad500.705"},{"issue":"10","key":"337_CR28","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/jvi.78.10.5194-5204.2004","volume":"78","author":"D Hochberg","year":"2004","unstructured":"Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA (2004) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 78(10):5194\u20135204. https:\/\/doi.org\/10.1128\/jvi.78.10.5194-5204.2004","journal-title":"J Virol"},{"issue":"9","key":"337_CR29","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.Ccr-10-3327","volume":"17","author":"S Hohaus","year":"2011","unstructured":"Hohaus S, Santangelo R, Giachelia M, Vannata B, Massini G, Cuccaro A et al (2011) The viral load of Epstein\u2013Barr Virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res 17(9):2885\u20132892. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-3327","journal-title":"Clin Cancer Res"},{"issue":"2","key":"337_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","volume":"6","author":"A Humar","year":"2006","unstructured":"Humar A, Michaels M (2006) American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6(2):262\u2013274. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01207.x","journal-title":"Am J Transplant"},{"issue":"9","key":"337_CR31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/cncr.28564","volume":"120","author":"M-F Ji","year":"2014","unstructured":"Ji M-F, Huang Q-H, Yu X, Liu Z, Li X, Zhang L-F et al (2014) Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer 120(9):1353\u20131360. https:\/\/doi.org\/10.1002\/cncr.28564","journal-title":"Cancer"},{"key":"337_CR32","doi-asserted-by":"publisher","first-page":"1627990","DOI":"10.3389\/fped.2025.1627990","volume":"13","author":"L Jia","year":"2025","unstructured":"Jia L, Yang H, Zhou Y, Meng Y, Zhang L, Lei X et al (2025) Analysis of risk factors for Epstein-Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. Front Pediatr 13:1627990. https:\/\/doi.org\/10.3389\/fped.2025.1627990","journal-title":"Front Pediatr"},{"issue":"3","key":"337_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ajh.22252","volume":"87","author":"K Jones","year":"2012","unstructured":"Jones K, Nourse JP, Keane C, Crooks P, Gottlieb D, Ritchie DS et al (2012) Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma. Am J Hematol 87(3):258\u2013265. https:\/\/doi.org\/10.1002\/ajh.22252","journal-title":"Am J Hematol"},{"issue":"1","key":"337_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-13-4","volume":"13","author":"R Kabyemera","year":"2013","unstructured":"Kabyemera R, Masalu N, Rambau P, Kamugisha E, Kidenya B, De Rossi A et al (2013) Relationship between Non-Hodgkin\u2019s lymphoma and blood levels of Epstein-Barr Virus in children in north-western Tanzania: a case control study. BMC Pediatr 13(1):4","journal-title":"BMC Pediatr"},{"issue":"18","key":"337_CR35","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","volume":"121","author":"J Kanakry","year":"2013","unstructured":"Kanakry J, Li H, Gellert LL, Lemas MV, Hsieh W-s, Hong F et al (2013) Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood 121(18):3547\u20133553. https:\/\/doi.org\/10.1182\/blood-2012-09-454694","journal-title":"Blood"},{"issue":"16","key":"337_CR36","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF et al (2016) The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood 127(16):2007\u20132017. https:\/\/doi.org\/10.1182\/blood-2015-09-672030","journal-title":"Blood"},{"issue":"5","key":"337_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","volume":"118","author":"JI Kawada","year":"2023","unstructured":"Kawada JI, Ito Y, Ohshima K, Yamada M, Kataoka S, Muramatsu H et al (2023) Updated guidelines for chronic active Epstein-Barr virus disease. Int J Hematol 118(5):568\u2013576. https:\/\/doi.org\/10.1007\/s12185-023-03660-5","journal-title":"Int J Hematol"},{"issue":"2","key":"337_CR38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80493-8","volume":"5","author":"G Khan","year":"1996","unstructured":"Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5(2):173\u2013179","journal-title":"Immunity"},{"key":"337_CR39","doi-asserted-by":"publisher","unstructured":"L\u00e4derach F, Piteros I, Fennell \u00c9, Bremer E, Last M, Schmid S et al (2025) EBV induces CNS homing of B cells attracting inflammatory T cells. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09378-0","DOI":"10.1038\/s41586-025-09378-0"},{"issue":"1","key":"337_CR40","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41467-019-11226-5","volume":"10","author":"WJ Lam","year":"2019","unstructured":"Lam WJ, Jiang P, Chan KA, Peng W, Shang H, Heung MM et al (2019) Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nature Commun 10(1):3256","journal-title":"Nature Commun"},{"issue":"4","key":"337_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2025.02.002","volume":"43","author":"WKJ Lam","year":"2025","unstructured":"Lam WKJ, Kang G, Chan CML, Lee VCT, Ma M-JL, Zhou Q et al (2025) Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma. Cancer Cell 43(4):728\u2013739.e5. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.002","journal-title":"Cancer Cell"},{"issue":"1","key":"337_CR42","first-page":"29","volume":"8","author":"KI Lei","year":"2002","unstructured":"Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM (2002) Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma. Clin Cancer Res 8(1):29\u201334","journal-title":"Clin Cancer Res"},{"issue":"6","key":"337_CR43","volume":"97","author":"J Li","year":"2025","unstructured":"Li J, Hou H, Song J, Yuan X, Ma M, Yang K et al (2025) Development of a diagnostic algorithm for Epstein-Barr virus-related diseases: a retrospective observational study. J Med Virol 97(6):e70421","journal-title":"J Med Virol"},{"issue":"26","key":"337_CR44","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1200\/jco.22.01979","volume":"41","author":"PJ Lou","year":"2023","unstructured":"Lou PJ, Jacky Lam WK, Hsu WL, Pfeiffer RM, Yu KJ, Chan CML et al (2023) Performance and operational feasibility of Epstein-Barr Virus-based screening for detection of nasopharyngeal carcinoma: direct comparison of two alternative approaches. J Clin Oncol 41(26):4257\u20134266. https:\/\/doi.org\/10.1200\/jco.22.01979","journal-title":"J Clin Oncol"},{"key":"337_CR45","doi-asserted-by":"publisher","first-page":"105579","DOI":"10.1016\/j.jcv.2023.105579","volume":"167","author":"LUP Ludvigsen","year":"2023","unstructured":"Ludvigsen LUP, Andersen AS, Hamilton-Dutoit S, Jensen-Fangel S, B\u00f8ttger P, Handberg KJ et al (2023) A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood. J Clin Virol 167:105579. https:\/\/doi.org\/10.1016\/j.jcv.2023.105579","journal-title":"J Clin Virol"},{"issue":"8","key":"337_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.ccell.2024.07.001","volume":"42","author":"J Lv","year":"2024","unstructured":"Lv J, Xu LX, Li ZX, Lin L, Wu CF, Quan TQ et al (2024) Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: the EP-SEASON study. Cancer Cell 42(8):1401\u20131414.e4. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.001","journal-title":"Cancer Cell"},{"issue":"6","key":"337_CR47","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3109\/10428191003746331","volume":"51","author":"ASC Machado","year":"2010","unstructured":"Machado ASC, Da Silva Robaina MC, Magalh\u00e3es De Rezende LM, Apa AG, Amo\u00eado ND, Bacchi CE et al (2010) Circulating cell-free and Epstein\u2013Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma 51(6):1020\u20131027. https:\/\/doi.org\/10.3109\/10428191003746331","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"337_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1469-0691.2009.02922.x","volume":"16","author":"T Martelius","year":"2010","unstructured":"Martelius T, Lappalainen M, Aalto SM, Nihtinen A, Hedman K, Anttila VJ (2010) Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia. Clin Microbiol Infect 16(6):657\u2013662. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02922.x","journal-title":"Clin Microbiol Infect"},{"key":"337_CR49","doi-asserted-by":"publisher","unstructured":"Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gonzalez MD et al (2024) Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)\u2217. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae104","DOI":"10.1093\/cid\/ciae104"},{"issue":"2","key":"337_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cam4.2710","volume":"9","author":"ND Montgomery","year":"2020","unstructured":"Montgomery ND, Randall C, Painschab M, Seguin R, Kaimila B, Kasonkanji E et al (2020) High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi. Cancer Med 9(2):552\u2013561. https:\/\/doi.org\/10.1002\/cam4.2710","journal-title":"Cancer Med"},{"issue":"3","key":"337_CR51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.28378","volume":"134","author":"DH Mulama","year":"2014","unstructured":"Mulama DH, Bailey JA, Foley J, Chelimo K, Ouma C, Jura WG et al (2014) Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case\u2013control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer 134(3):645\u2013653","journal-title":"Int J Cancer"},{"issue":"11","key":"337_CR52","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/cas.12812","volume":"106","author":"A Okamoto","year":"2015","unstructured":"Okamoto A, Yanada M, Miura H, Inaguma Y, Tokuda M, Morishima S et al (2015) Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma. Cancer Sci 106(11):1576\u20131581. https:\/\/doi.org\/10.1111\/cas.12812","journal-title":"Cancer Sci"},{"issue":"17","key":"337_CR53","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1182\/blood-2012-12-470393","volume":"122","author":"DE Ouedraogo","year":"2013","unstructured":"Ouedraogo DE, Makinson A, Vendrell J-P, Casanova M-L, Nagot N, Cezar R et al (2013) Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy. Blood 122(17):3030\u20133033. https:\/\/doi.org\/10.1182\/blood-2012-12-470393","journal-title":"Blood"},{"issue":"12","key":"337_CR54","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jamaoncol.2024.4354","volume":"10","author":"JJ Pan","year":"2024","unstructured":"Pan JJ, Mai HQ, Ng WT, Hu CS, Li JG, Chen XZ et al (2024) Ninth version of the AJCC and UICC nasopharyngeal cancer TNM staging classification. JAMA Oncol 10(12):1627\u20131635. https:\/\/doi.org\/10.1001\/jamaoncol.2024.4354","journal-title":"JAMA Oncol"},{"issue":"10","key":"337_CR55","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1158\/1078-0432.Ccr-16-1691","volume":"23","author":"S Parpart-Li","year":"2017","unstructured":"Parpart-Li S, Bartlett B, Popoli M, Adleff V, Tucker L, Steinberg R et al (2017) The effect of preservative and temperature on the analysis of circulating tumor DNA. Clin Cancer Res 23(10):2471\u20132477. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-1691","journal-title":"Clin Cancer Res"},{"issue":"3","key":"337_CR56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jcv.2011.11.010","volume":"53","author":"S Ruf","year":"2012","unstructured":"Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J et al (2012) Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. J Clin Virol 53(3):186\u2013194. https:\/\/doi.org\/10.1016\/j.jcv.2011.11.010","journal-title":"J Clin Virol"},{"issue":"2","key":"337_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00019606-200406000-00001","volume":"13","author":"JL Ryan","year":"2004","unstructured":"Ryan JL, Fan H, Swinnen LJ, Schichman SA, Raab-Traub N, Covington M et al (2004) Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 13(2):61\u201368","journal-title":"Diagn Mol Pathol"},{"key":"337_CR58","doi-asserted-by":"publisher","first-page":"101475","DOI":"10.1016\/j.lanwpc.2025.101475","volume":"55","author":"NF Saba","year":"2025","unstructured":"Saba NF, Ma BBY (2025) The potential of real-time dynamic disease monitoring with circulating tumor DNA: important lessons from Epstein-Barr virus-related nasopharyngeal carcinoma. Lancet Reg Health West Pac 55:101475. https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101475","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"337_CR59","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.diagmicrobio.2016.04.017","volume":"85","author":"M Salmona","year":"2016","unstructured":"Salmona M, Fourati S, Feghoul L, Scieux C, Thiriez A, Simon F et al (2016) Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system. Diagn Microbiol Infect Dis 85(4):428\u2013432. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.04.017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"337_CR60","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1128\/jcm.03336-15","volume":"54","author":"T Semenova","year":"2016","unstructured":"Semenova T, Lupo J, Alain S, Perrin-Confort G, Grossi L, Dimier J et al (2016) Multicenter evaluation of whole-blood Epstein-Barr viral load standardization using the WHO International Standard. J Clin Microbiol 54(7):1746\u20131750. https:\/\/doi.org\/10.1128\/jcm.03336-15","journal-title":"J Clin Microbiol"},{"issue":"8","key":"337_CR61","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/bloodadvances.2020001511","volume":"4","author":"M Shamay","year":"2020","unstructured":"Shamay M, Kanakry JA, Low JS, Horowitz NA, Journo G, Ahuja A et al (2020) CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma. Blood Adv 4(8):1624\u20131627","journal-title":"Blood Adv"},{"issue":"6","key":"337_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/08880018.2013.796026","volume":"30","author":"M Sinha","year":"2013","unstructured":"Sinha M, Rao CR, Shafiulla M, Appaji L, Bs AK, Sumati BG et al (2013) Cell-free Epstein\u2013Barr viral loads in childhood Hodgkin lymphoma: a study from South India. Pediatr Hematol Oncol 30(6):537\u2013543. https:\/\/doi.org\/10.3109\/08880018.2013.796026","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"337_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0463.2010.02685.x","volume":"119","author":"M Spacek","year":"2011","unstructured":"Spacek M, Hubacek P, Markova J, Zajac M, Vernerova Z, Kamaradova K et al (2011) Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. Apmis 119(1):10\u201316. https:\/\/doi.org\/10.1111\/j.1600-0463.2010.02685.x","journal-title":"Apmis"},{"issue":"16","key":"337_CR64","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/QAD.0b013e3282eeeba0","volume":"21","author":"SJ Stevens","year":"2007","unstructured":"Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW et al (2007) Aberrant Epstein\u2013Barr virus persistence in HIV carriers is characterized by anti-Epstein\u2013Barr virus IgA and high cellular viral loads with restricted transcription. Aids 21(16):2141\u20132149","journal-title":"Aids"},{"issue":"23","key":"337_CR65","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y et al (2011) Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood 118(23):6018\u20136022. https:\/\/doi.org\/10.1182\/blood-2011-05-354142","journal-title":"Blood"},{"issue":"3","key":"337_CR66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.coviro.2013.04.005","volume":"3","author":"DA Thorley-Lawson","year":"2013","unstructured":"Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M (2013) The pathogenesis of Epstein\u2013Barr virus persistent infection. Curr Opin Virol 3(3):227\u2013232","journal-title":"Curr Opin Virol"},{"key":"337_CR67","doi-asserted-by":"publisher","unstructured":"Volesky-Avellaneda K, Xian RR, Young TB, Baugher RN, Ogwang MD, Kerchan P et al (2025) Circulating plasma EBV DNA: a potential tool to facilitate diagnosis of pediatric Burkitt lymphoma in sub-Saharan Africa. Blood Glob Hematol:100025. https:\/\/doi.org\/10.1016\/j.bglo.2025.100025","DOI":"10.1016\/j.bglo.2025.100025"},{"issue":"6","key":"337_CR68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH et al (2014) Reactivation of multiple viruses in patients with sepsis. PloS one 9(6):e98819","journal-title":"PloS one"},{"issue":"10","key":"337_CR69","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","volume":"120","author":"ZY Wang","year":"2012","unstructured":"Wang ZY, Liu QF, Wang H, Jin J, Wang WH, Wang SL et al (2012) Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy. Blood 120(10):2003\u20132010. https:\/\/doi.org\/10.1182\/blood-2012-06-435024","journal-title":"Blood"},{"issue":"8","key":"337_CR70","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1080\/10428194.2018.1563690","volume":"60","author":"XX Wang","year":"2019","unstructured":"Wang XX, Li PF, Bai B, Gao Y, Rong QX, Cai QQ et al (2019) Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK\/T-cell lymphoma treated with P-GEMOX protocol. Leuk Lymphoma 60(8):1917\u20131925. https:\/\/doi.org\/10.1080\/10428194.2018.1563690","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"337_CR71","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/ijc.30682","volume":"140","author":"KD Westmoreland","year":"2017","unstructured":"Westmoreland KD, Montgomery ND, Stanley CC, El-Mallawany NK, Wasswa P, van der Gronde T et al (2017) Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer 140(11):2509\u20132516. https:\/\/doi.org\/10.1002\/ijc.30682","journal-title":"Int J Cancer"},{"issue":"18","key":"337_CR72","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.clinbiochem.2016.09.009","volume":"49","author":"FCK Wong","year":"2016","unstructured":"Wong FCK, Sun K, Jiang P, Cheng YKY, Chan KCA, Leung TY et al (2016) Cell-free DNA in maternal plasma and serum: a comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clin Biochem 49(18):1379\u20131386. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.09.009","journal-title":"Clin Biochem"},{"key":"337_CR73","doi-asserted-by":"publisher","first-page":"804083","DOI":"10.3389\/fonc.2021.804083","volume":"11","author":"RR Xian","year":"2021","unstructured":"Xian RR, Kinyera T, Otim I, Sampson JN, Nabalende H, Legason ID et al (2021) Plasma EBV DNA: a promising diagnostic marker for endemic Burkitt lymphoma. Front Oncol 11:804083. https:\/\/doi.org\/10.3389\/fonc.2021.804083","journal-title":"Front Oncol"},{"key":"337_CR74","doi-asserted-by":"publisher","first-page":"105320","DOI":"10.1016\/j.jcv.2022.105320","volume":"157","author":"Z Yan","year":"2022","unstructured":"Yan Z, Yao Z, Wang H, Yao S, Wang X, Gao Y et al (2022) Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK\/T-cell lymphoma. J Clin Virol 157:105320. https:\/\/doi.org\/10.1016\/j.jcv.2022.105320","journal-title":"J Clin Virol"},{"issue":"13","key":"337_CR75","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood.V96.13.4055","volume":"96","author":"J Yang","year":"2000","unstructured":"Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H et al (2000) Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96(13):4055\u20134063","journal-title":"Blood"},{"key":"337_CR76","doi-asserted-by":"publisher","unstructured":"Yang X, Chen X, Shen W, Wang S, Wang T, Wang Y et al (2025) Post antiretroviral treatment dynamics of blood EBV DNA among people with HIV: a prospective cohort study. AIDS. https:\/\/doi.org\/10.1097\/qad.0000000000004214","DOI":"10.1097\/qad.0000000000004214"},{"key":"337_CR77","doi-asserted-by":"publisher","unstructured":"Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X et al (2019) Determination of Epstein-Barr Virus\u2013infected lymphocyte cell types in peripheral blood mononuclear cells as a valuable diagnostic tool in hematological diseases. Open Forum Infect Dis 6(5). https:\/\/doi.org\/10.1093\/ofid\/ofz171","DOI":"10.1093\/ofid\/ofz171"},{"key":"337_CR78","doi-asserted-by":"publisher","first-page":"115098","DOI":"10.1016\/j.ejca.2024.115098","volume":"213","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhu L, Lv W, Xu T, Shen C, Qian W et al (2024) Liquid biopsy with plasma Epstein-Barr virus DNA characterizes biological relapse for the prediction of cancer recurrence in non-disseminated nasopharyngeal carcinoma. Eur J Cancer 213:115098. https:\/\/doi.org\/10.1016\/j.ejca.2024.115098","journal-title":"Eur J Cancer"},{"issue":"33","key":"337_CR79","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2217\/fon-2023-0818","volume":"19","author":"P Zhou","year":"2023","unstructured":"Zhou P, Zhou J, Lian CL, Yu YF, Zhou R, Lin Q et al (2023) Residual plasma Epstein-Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma. Future Oncol 19(33):2227\u20132235. https:\/\/doi.org\/10.2217\/fon-2023-0818","journal-title":"Future Oncol"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:35:09Z","timestamp":1770132909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/82_2025_337","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"4 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}